Injectable Platelet Rich Fibrin With Non Surgical Periodontal Therapy

NCT ID: NCT04070729

Last Updated: 2019-08-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-28

Study Completion Date

2020-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Clinical evaluation of local subgingival application of injectable platelet-rich fibrin ( i-PRF ) for chronic periodntitis as adjunctive to non surgical therapy and compare it with hyaluronic acid.

120 periodontal patients will receive a scaling and root planing ( non surgical periodontal therapy). Equal number of patients will receive subgingival application of i-PRF, hyaluronic acid or placebo gel as the adjunction to non surgical therapy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is to evaluate and compare the clinical efficacy of subgingival application of i-PRF and hyaluronic acid gel as adjunctive to non-surgical periodontal therapy. 120 periodontal patients will receive traditional mechanical supra and subgingival scaling and root planing. Patients were randomly allocated in three groups. Group 1, 2 and 3 will receive subginigval application of placebo, hyaluronic acid gel and i prf respectively. Clinical parameters will be evaluated: plaque index (PI), gingival index (GI), bleeding on probing (BOP), probing depth (PD), clinical attachment level (CAL), gingival recession (GR). Clinical measurements will be performed at baseline, 1 month and at 3 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

CHRONIC PERIODONTITIS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Negative control

Placebo gel

Group Type PLACEBO_COMPARATOR

Placebo gel

Intervention Type OTHER

Localized subgingival application

Test group 1

Hyaluronic acid gel

Group Type EXPERIMENTAL

Hyaluronic acid gel

Intervention Type DRUG

Localized subgingival application

Test group 2

injectable prf

Group Type EXPERIMENTAL

Platelet rich fibrin

Intervention Type BIOLOGICAL

Localized subgingival application

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Placebo gel

Localized subgingival application

Intervention Type OTHER

Hyaluronic acid gel

Localized subgingival application

Intervention Type DRUG

Platelet rich fibrin

Localized subgingival application

Intervention Type BIOLOGICAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Cellulose gel

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients are in general good health.
* Patients having minimum of 20 permanent teeth.
* They have not taken medication known to interfere with periodontal tissue health or healing in the preceding 6 months.
* Presence of periodontal pockets (≥5 mm) and clinicala ttachment level \> 5 mm.

Exclusion Criteria

* Immunosuppressive systemic diseases (like cancer, AIDS, diabetes etc.)
* Clotting and Hematological disorders
* Patients with grade III mobility.
* Patients with smoking and alcohol consuming habit.
* Pregnant and lactating female.
* Medications influence on the gingival and periodontal tissues (like calcium channel blockers, or Long-term steroid use)
* The teeth with poor filling and ill fitted restorations
Minimum Eligible Age

30 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute of Dental Sciences, Bareilly, Uttar Pradesh, India

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ASHISH AGARWAL

Clinical professor, institute of dental sciences, bareilly

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IEC/IDS50/2019

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PRF Therapy for Pocket Reduction
NCT05908929 COMPLETED NA